Redefining Breast Cancer Detection

Transforming detection of breast cancer for all women.

Breast cancer is the most common cancer in women of all ages globally, with the highest mortality rate. 12.9%of women will experience breast cancer, in their lifetime (that’s 500 million women alive today). Survival rates are in excess of 99%, if treatment starts whilst it’s still localised in the breast. But, survival rates drop significantly, once it’s been able to spread.

Early detection is critical in minimising the number of women who will die from breast cancer. At Micrima we are developing tools that can be used to increase early diagnosis of breast cancer, that are effective for women of all ages and breast densities.

Mi~Scan is a unique device that can measure breast tissue properties, before a Mammogram. This enables clinicians to chose the best imaging technique, for each patients breast tissue composition

  • Unlike a mammogram, which uses X-rays, Micrima technology uses radio waves to scan. These are the same frequencies that are used by wi-fi or a mobile phone, making our device safe to use, as frequently as required.

  • When scanned by a our device, your breast will be brought in to contact with our patented antennae, with just enough contact to ensure good transfer of radio waves in to the breast.

  • Currently, the only screening available in the UK is by a mammogram between the ages of 50-71. However, a mammogram is impacted by dense breast tissue, which can obscure any potential tumors in the breast. Younger women often have dense breast tissue which can reduce as a woman gets older. Yet, 40% of women of a screening age still have dense breasts.

    Micrima technology can scan women of all ages and breast densities, as frequently as required.

Why do we want to transform breast cancer detection?

  • Early Detection

    Patients who have their breast cancers found early have significantly higher survival rates. Micrima are aiming to open breast cancer screening to all ages, to improve early detection.

  • Breast Density

    Dense breasts increases your risk of breast cancer and makes it difficult to detect on a mammogram. Micrima technology is effective in all breast densities.

  • Your User Experience

    Mammograms also compress the breast, which can be uncomfortable for some women. Micrima technology is non-ionising, uses radio waves and no breast compression.

“What you’re developing is a new concept, and to be honest with you, that’s what we need because we can’t deliver using the current concept.”

- Dr Nisha Sharma, Clinical lead of Leeds NHS Foundation Trust Breast Services and Chair of the Micrima Clinical Advisory Board